Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models. (Q40198514)
Jump to navigation
Jump to search
scientific article published on December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models. |
scientific article published on December 2006 |
Statements
Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models (English)
Barbara Kuske
Catherine Naughton
Kate Moore
Kenneth G Macleod
William R Miller
Simon P Langdon
David A Cameron
1 December 2006